REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Szabo Pharma Bt. (Hungary)

Main Activities: Pharmacies and Drug Stores
Full name: SZABO PHARMA Gyogyszer-kiskereskedelmi es Szolgaltato Bt. Profile Updated: August 16, 2023
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English & Hungarian Download a sample report

Szabo Pharma Bt. is a company in Hungary, with a head office in Gadoros. It operates in the Pharmacies and Drug Stores sector. The company was established on July 19, 2000. It currently has a total number of 4 (2023) employees. The latest financial highlights indicate a net sales revenue increase of 7.4% in 2022. A growth of 73.79% was recorded in its total assets. In 2022, Szabo Pharma Bt.’s net profit margin increased by 0.76%.

Headquarters
Kossuth utca 28.
Gadoros; Bekes; Postal Code: 5932

Contact Details: Purchase the Szabo Pharma Bt. report to view the information.

Basic Information
Total Employees:
Purchase the Szabo Pharma Bt. report to view the information.
Outstanding Shares:
Purchase the Szabo Pharma Bt. report to view the information.
Registered Capital:
Purchase the Szabo Pharma Bt. report to view the information.
Financial Auditors:
Purchase the Szabo Pharma Bt. report to view the information.
Incorporation Date:
July 19, 2000
Key Executives
Purchase this report to view the information.
Managing Director
Ownership Details
Purchase this report to view the information.
Purchase this report to view the information.
Subsidiaries
Gad-Med Gadorosi Medicina Beteti Tarsasag
Company Performance
Financial values in the chart are available after Szabo Pharma Bt. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency HUF. Absolute financial data is included in the purchased report.
Net sales revenue
7.4%▲
Total operating revenue
10.4%▲
Operating profit (EBIT)
10.16%▲
EBITDA
22.24%▲
Net Profit (Loss) for the Period
18.38%▲
Total assets
73.79%▲
Total equity
11.85%▲
Operating Profit Margin (ROS)
0.21%▲
Net Profit Margin
0.76%▲
Return on Equity (ROE)
3.84%▲
Quick Ratio
-0.95%▼
Cash Ratio
-0.93%▼

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo